Showing 20 of 100 recruiting trials for “carcinoma-of-esophagus”
RecruitingNCT06790797 ↗
Investigating the Biomarkers in Tumor and Peripheral Blood to Evaluate the Efficacy of Cancer Immunotherapy in Chest Cancer Patients
A Study Involving Neoadjuvant Chemoradiotherapy with Hypofractionated Radiotherapy in Patients with Esophageal and Gastroesophageal Junction Adenocarcinoma
Perioperative Analgesia Modes in Minimally Invasive Esophagectomy
🏥 Cancer Institute and Hospital, Chinese Academy of Medical Sciences📍 1 site📅 Started Oct 2022View details ↗
RecruitingNCT06009705 ↗
Toripalimab Combined With Radiotherapy and S-1 for Older Patients With Esophageal Cancer
👨⚕️ Wenbin Shen, PhD, Hebei Medical University Fourth Hospital📍 1 site📅 Started Oct 2022View details ↗
RecruitingNCT06515964 ↗
China Early Esophageal Cancer Cohort
The Efficacy of Neoadjuvant Chemoradiotherapy in Comparison With Neoadjuvant Chemotherapy in Patients With Resectable Squamous Cell Esophageal Cancer
Anti-Migration System for Anti-reflux Oeso-gastric Stent (ANTIMIG)
Watch and Wait for NeoAdjuvant Concurrent Radiochemotherapy Combined With Camrelizumab in Patients With Resectable ESCC
A Phase II Study of CRT Combined With QL1706 in ESCC Patients
RecruitingNCT05443841 ↗
Value of Pleural Lavage Cytology in Resectable Esophageal Carcinoma Eastern Cooperative Thoracic Oncology Projects 2005, ECTOP-2005)
RecruitingNCT06393140 ↗
The Study on the Mechanism of Radiotherapy-elicited Immune Response
Surgery or Chemoradiotherapy for Cervical Esophageal Cancer
👨⚕️ Jie He, MD, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College📍 1 site📅 Started Apr 2022View details ↗
TRAstuzumab and Pertuzumab for HER2+ Resectable Oesophageal Cancer
🏥 Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)📍 1 site📅 Started Mar 2022View details ↗
Camrelizumab Plus Neoadjuvant Chemotherapy or Chemoradiotherapy Versus Chemoradiotherapy in Resectable ESCC.
Comparison of Chemoradiotherapy and Chemoradiotherapy Combined With Consolidation Chemotherapy for ESCC
👨⚕️ Xiaolin GE, MM, The First Affiliated Hospital with Nanjing Medical University📍 1 site📅 Started Jun 2021View details ↗
Fluorescence Image Guided Foregut Surgery
👨⚕️ Silvana PERRETTA, MD, PhD, Service de Chirurgie Digestive et Endocrinienne, NHC, Strasbourg📍 1 site📅 Started Apr 2021View details ↗
RecruitingNCT07080437 ↗
An Observational Study on the Safety and Efficacy of Immunotherapy Combined With Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma
RecruitingNCT04455282 ↗
CIRCULATing Biomarkers for Individualized Surgical Therapy in gastroEsophageal Cancer - Phase 1
👨⚕️ Nikolas Stoecklein, MD, Surgery, University Hospital Düsseldorf Germany📍 2 sites📅 Started Feb 2021View details ↗
Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer
RAMIE Versus MIE for Resectable Esophageal Cancer, a Randomized Controlled Trial (ROBOT-2 Trial).
👨⚕️ Peter Grimminger, MD,PhD, JGU Medizin Mainz, dept. AVTC📍 1 site📅 Started Jan 2021View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →